A 2023 hearing-care investigation considered retail in Ras Al Khaimah and a later Abu Dhabi clinical expansion, with separate product, facility and professional questions.
The activity code is confirmed for the selected authority and exact scope before application.
Ras Al Khaimah / Abu Dhabi
Separate product retail from patient-facing audiology and ENT services. Ras Al Khaimah and Abu Dhabi economic and health authorities must confirm their respective activity entries.
Four phases, 10 checkpoints. See the route at a glance, then open a checkpoint for the work, owner and timing. Daily updates continue during active work.
Confirm the route and open your file.
Activity, legal form and Abu Dhabi
Owner / You and VantablackNamed team, checklist and your project timeline
Owner / VantablackDocuments and activity checks.
Passports, KYC and anything the activity needs
Owner / You, checked by VantablackSubmitted to the Abu Dhabi economic authority
Owner / Vantablack, then the authorityRequired before you can operate this activity
Owner / Ministry of HealthPremises and the licence decision.
Premises lease and registration
Owner / You and VantablackYour company exists; documents in your workspace
Owner / The authorityFollow-on work in your agreed scope.
Immigration file for you and your team
Owner / Vantablack PRO teamBank application, VAT and Corporate Tax registration
Owner / Vantablack and the bankList your services on the Ecosystem and receive requests
Owner / You, on VantablackTime markers are our service standards; authority steps follow the authority’s own timeline, and approvals are the authority’s decision. Your accepted quote confirms which post-licence services are included. Sales depend on licensing, approvals and demand.
Read the requirement, the constraint and the proposed route together. The value of this case is the reasoning behind the setup, rather than an activity name in isolation.
The topology shows how the commercial hearing-aid business, medical-facility approval and Abu Dhabi clinical expansion connect without confusing retail permission with healthcare authorisation.
growth objective
This describes a 2023 client investigation into hearing-aid and accessory retail in Ras Al Khaimah, followed by possible hearing-screening and ENT-related clinical services in Abu Dhabi. The proposal crossed product, premises and professional boundaries. The record does not establish the original RAK approving body or a completed Abu Dhabi branch launch.
Separate the retail activity, product-supply permissions and patient-facing services. Verify the original RAK approvals from the client file, then assess the Abu Dhabi entity, facility and professional route for the exact services proposed. Keep historical advice distinct from current requirements; no completed expansion or transferred clinical permission is claimed.
MOHAP’s current private-facility service material expressly includes Ras Al Khaimah within its Northern Emirates remit. That provides jurisdiction context, not proof that MOHAP approved this client’s retail activity in 2023. Check the original economic licence, health-authority correspondence and premises conditions before naming the historical approver.
MOHAP: private-facility jurisdiction includes Ras Al Khaimah — checked 20 October 2026. Read the official publication.
DOH publishes separate facility licensing/design guidance and an audiology scope of practice effective October 2026. The latter applies to DOH-licensed providers and audiology services. Confirm the facility category, audiology and ENT service permissions and individual professional scope before planning clinical operation.
DOH Health Facility Guidelines: licensing and design approvals — checked 20 October 2026. Read the official publication.
DOH Audiology scope of practice, published May 2026; effective October 2026 — checked 20 October 2026. Read the official publication.
Check the proposed hearing-aid models and supplier’s EDE medical-device authorisation and relevant import/trading permissions. EDE’s device service registers equipment for importing and trading in the UAE and requires the marketing-authorisation holder to be registered first. Device authorisation does not itself license a clinic or its professionals.
EDE: Marketing Authorization for a Medical Device — checked 20 October 2026. Read the official publication.
The record does not confirm retail opening, branch incorporation, a clinical facility licence, actual fees or elapsed dates. Current rules do not prove what was approved in 2023. Separate product supply, each emirate’s facility permissions and individual practice rights before committing to an expansion.
The investigation separates product retail, premises and clinical practice across jurisdictions. Completed approvals and opening milestones remain unrecorded.
Assess the clinical premises, service scope, design and building/sector permissions before committing to works. A company-address package does not license treatment premises.
Quote company and professional work separately from product dossiers or clinical approvals, premises, equipment and operating costs. No actual case budget or verified authority tariff is supplied here.
Planning guidance, not a statement of this client’s costs or completed approvals. Confirm the specific scope and quotation.
A published setup investigation is not evidence of licence issuance or a guaranteed commercial result. Where a historical outcome is stated, it applies to that case. Current permissions, costs and timing require a fresh review.
Setup AssistantClassification follows what is actually done with patients or products. Corporate formation does not by itself authorise clinical treatment, a health facility or each product.
A clinical service, restricted ingredient, new treatment or additional product can introduce a separate regulatory path.
